Clinical trial
Long-Term Study of Nitisinone to Treat Alkaptonuria
NCT00107783 · National Human Genome Research Institute (NHGRI), NIH · Completed
Key facts
| NCT number | NCT00107783 |
|---|---|
| Title | Long-Term Study of Nitisinone to Treat Alkaptonuria |
| Official title | Long-Term Clinical Trial of Nitisinone in Alkaptonuria |
| Lead sponsor | National Human Genome Research Institute (NHGRI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alkaptonuria |
| Intervention type | Drug |
| Interventions | Nitisinone (NTBC) |
| Enrollment | 40 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Apr 8, 2005 |
| Last update posted | Aug 26, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: